Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-12-18

Clinical Trial Update: Precision Radiotherapy Using MR-linac for Pancreatic Neuroendocrine Tumours in MEN1 Patients [NA]

View source ↗

Summary

This document reports a clinical trial update for precision radiotherapy using MR-linac in pancreatic neuroendocrine tumors in MEN1 patients, currently recruiti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: J.M. de Laat | Conditions: Neuroendocrine Tumor of Pancreas, Multiple Endocrine Neoplasia Type 1 | NA | Status: RECRUITING